News IBM Watson to help personalise cancer care in China Watson for Oncology will be deployed across 21 Chinese hospitals to aid in care decisions.
Views & Analysis Trends in clinical research in China A large patient pool plus growing market opportunities are making China increasingly attractive for clinical trials.
News BeyondSpring looks to tap China for lung cancer drug develop... Company's alliance in huge lung cancer market could pay off
News China to begin first in-human CRISPR trial next month Phase 1 trial will investigate safety and tolerability in non-small cell lung cancer.
News Remepy's hybrid Parkinson's therapy poised for phase 3 Remepy's Hybridopa therapy for Parkinson's, which combines an app with levodopa therapy, has shown efficacy in a phase 2 pilot study.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
